Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone – finally an effective chemotherapy

This publication has 17 references indexed in Scilit:

• Current strategies in the management of hormone refractory prostate cancer
  Cancer Treatment Reviews, 2003
• What's new in the treatment of advanced prostate cancer?
  European Journal of Cancer, 2003
• Chemotherapy for prostate cancer
  Urology, 2002
• Current Status of Cytotoxic Chemotherapy in Hormone Refractory Prostate Cancer
  European Urology, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study
  Journal of Clinical Oncology, 1999
• SECONDARY HORMONAL MANIPULATIONS IN HORMONE REFRACTORY PROSTATE CANCER
  Urologic Clinics of North America, 1999
• Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell lines
  British Journal of Urology, 1997
• Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
  Journal of Clinical Oncology, 1996
• Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer
  Cancer, 1993